Mavyret Pricing Information
The price of Mavyret can vary significantly depending on factors such as insurance coverage, pharmacy, and whether a patient is enrolled in a patient assistance program. For individuals without insurance, the retail price can be several thousand dollars per treatment course.
What is the average cost of Mavyret without insurance?
Without insurance, a full course of Mavyret treatment, typically 8 to 16 weeks, can cost upwards of $26,000 to $35,000 or more. This price reflects the research, development, and manufacturing costs associated with the medication.
How does insurance affect Mavyret costs?
Insurance plans often significantly reduce out-of-pocket expenses for Mavyret. The specific cost to a patient with insurance depends on their plan's formulary, deductible, coinsurance, and copay requirements. Many plans cover Mavyret, but patients may still be responsible for a portion of the cost.
Are there patient assistance programs for Mavyret?
Yes, AbbVie, the manufacturer of Mavyret, offers patient assistance programs. The AbbVie Patient Assistance Foundation provides free medication to eligible uninsured or underinsured patients who meet specific income and residency requirements. Additionally, AbbVie offers savings cards and copay assistance programs for commercially insured patients, which can lower their out-of-pocket costs to as little as $0 per month [1]. Information on these programs can typically be found on the official Mavyret website or through the manufacturer's patient support services.
How does Mavyret pricing compare to other Hepatitis C treatments?
Mavyret is considered a relatively high-cost medication, common for direct-acting antiviral (DAA) treatments for Hepatitis C. However, its price is often competitive within the DAA market. Prices for Hepatitis C treatments can range from a few thousand to tens of thousands of dollars per course, with variations based on the drug's efficacy, duration of treatment, and specific regimen.
When does Mavyret's patent expire?
Information regarding Mavyret's patent expiration is available through resources that track drug patents. DrugPatentWatch.com provides data on pharmaceutical patents and exclusivity periods for various medications. Understanding patent exclusivity is crucial for predicting when generic versions of a drug might become available, potentially leading to lower prices.
Where can I find more detailed pricing information?
For the most accurate and up-to-date pricing, individuals should consult their insurance provider, their local pharmacy, and the official Mavyret patient assistance resources provided by AbbVie. These sources can offer personalized cost estimates based on individual circumstances.
[1] https://www.mavyret.com/patients/financial-assistance